Search Results

Return to List
Results 21–40 of 96
Title Date

Direct-to-Consumer Marketing of Genetic Testing

Number 409

Reaffirmed 2014

ABSTRACT Marketing of genetic testing although similar to directtoconsumer advertising of prescription drugs raises additional concerns and considerations These include issues of limited knowledge among patients and health care providers of available genetic tests difficulty in interpretation of g...

June 2008

PDF Format

Ethical Issues in Genetic Testing

Number 410

(Reaffirmed 2014)

ABSTRACT Genetic testing is poised to play an increasing role in the practice of obstetrics and gynecology To assure patients of the highest quality of care physicians should become familiar with the currently available array of genetic tests and the tests limitations Clinicians should be able to ...

June 2008

PDF Format

Spinal Muscular Atrophy

Number 432

Reaffirmed 2014

ABSTRACT Spinal muscular atrophy SMA is an autosomal recessive neurodegenerative disease that results from degeneration of spinal cord motor neurons leading to atrophy of skeletal muscle and overall weakness In current practice patients with a family history of SMA are being offered carrier screen...

May 2009

PDF Format

Oral Intake During Labor

Number 441

(Reaffirmed 2013)

ABSTRACT There is insufficient evidence to address the safety of any particular fasting period for solids in obstetric patients Expert opinion supports that patients undergoing either elective cesarean delivery or elective postpartum tubal ligation should undergo a fasting period of 68 hours Adher...

September 2009

PDF Format

Preconception and Prenatal Carrier Screening for Genetic Diseases in Individuals of Eastern European Jewish Descent

Number 442

(Reaffirmed 2014, Replaces No. 298, August 2004)

ABSTRACT Certain autosomal recessive disease conditions are more prevalent in individuals of Eastern European Jewish Ashkenazi descent Previously the American College of Obstetricians and Gynecologists recommended that individuals of Eastern European Jewish ancestry be offered carrier screening fo...

October 2009

PDF Format

Air Travel During Pregnancy

Number 443

(Reaffirmed 2014, Replaces No. 264, December 2001)

ABSTRACT In the absence of obstetric or medical complications pregnant women can observe the same precautions for air travel as the general population and can fly safely Pregnant women should be instructed to continuously use their seat belts while seated as should all air travelers Pregnant air t...

October 2009

PDF Format

Magnesium Sulfate Before Anticipated Preterm Birth for Neuroprotection

Number 455

Reaffirmed 2015

Abstract Numerous large clinical studies have evaluated the evidence regarding magnesium sulfate neuroprotection and preterm births The Committee on Obstetric Practice and the Society for MaternalFetal Medicine recognize that none of the individual studies found a benefit with regard to their prim...

March 2010

PDF Format

Preparing for Disasters: Perspectives on Women

Number 457

(Reaffirmed 2014)

ABSTRACT Emergency plans that specifically address the needs of women infants and children during disasters are currently underdeveloped in the United States Pregnant women infants and children are adversely affected by disasters resulting in an increased number of infants with intrauterine growth...

June 2010

PDF Format

Moderate Caffeine Consumption During Pregnancy

Number 462

Reaffirmed 2015

ABSTRACT Moderate caffeine consumption less than 200 mg per day does not appear to be a major contributing factor in miscarriage or preterm birth The relationship of caffeine to growth restriction remains undetermined A final conclusion cannot be made at this time as to whether there is a correlat...

August 2010

PDF Format

Carrier Screening for Fragile X Syndrome

Number 469

(Reaffirmed 2014, Replaces No. 338, June 2006)

ABSTRACT Fragile X syndrome is the most common inherited form of mental retardation The syndrome occurs in approximately 1 in 3600 males and 1 in 40006000 females Approximately 1 in 250 females carry the premutation DNAbased molecular analysis is the preferred method of diagnosis for fragile X syn...

October 2010

PDF Format

Smoking Cessation During Pregnancy

Number 471

(Replaces No. 316, October 2005. Reaffirmed 2015)

ABSTRACT Smoking is the one of the most important modifiable causes of poor pregnancy outcomes in the United States and is associated with maternal fetal and infant morbidity and mortality The physical and psychologic addiction to cigarettes is powerful however the compassionate intervention of th...

November 2010

PDF Format

Planned Home Birth

Number 476

Reaffirmed 2015

ABSTRACT Although the Committee on Obstetric Practice believes that hospitals and birthing centers are the safest setting for birth it respects the right of a woman to make a medically informed decision about delivery Women inquiring about planned home birth should be informed of its risks and ben...

February 2011

PDF Format

Nonobstetric Surgery During Pregnancy

Number 474

(Replaces No. 284, August 2003, Reaffirmed 2015)

ABSTRACT The American College of Obstetricians and Gynecologists Committee on Obstetric Practice acknowledges that the issue of nonobstetric surgery during pregnancy is an important concern for physicians who care for women It is important for a physician to obtain an obstetric consultation before...

February 2011

PDF Format

Family History as a Risk Assessment Tool

Number 478

(Reaffirmed 2015)

ABSTRACT Family history plays a critical role in assessing the risk of inherited medical conditions and single gene disorders Several methods have been established to obtain family medical histories including the family history questionnaire or checklist and the pedigree The screening tool selecte...

March 2011

PDF Format

Methamphetamine Abuse in Women of Reproductive Age

Number 479

(Reaffirmed 2013)

ABSTRACT Methamphetamine abuse has continued to increase in the United States since the late 1980s with its use spreading from the West Coast to areas across the country Methamphetamine use in pregnancy endangers the health of the woman and increases the risk of low birth weight and small for gest...

March 2011

PDF Format

Prevention of Early-Onset Group B Streptococcal Disease in Newborns

Number 485

(Replaces No. 279, December 2002, Reaffirmed 2015)

ABSTRACT In 2010 the Centers for Disease Control and Prevention revised its guidelines for the prevention of perinatal group B streptococcal disease Although universal screening at 3537 weeks of gestation and intrapartum antibiotic prophylaxis continue to be the basis of the prevention strategy th...

April 2011

PDF Format

Update on Carrier Screening for Cystic Fibrosis

Number 486

(Reaffirmed 2014, Replaces No. 325, December 2005)

ABSTRACT In 2001 the American College of Obstetricians and Gynecologists and the American College of Medical Genetics introduced guidelines for prenatal and preconception carrier screening for cystic fibrosis The American College of Obstetricians and Gynecologists Committee on Genetics has updated...

April 2011

PDF Format

Sulfonamides, Nitrofurantoin, and Risk of Birth Defects

Number 494

(Reaffirmed 2015)

Abstract The evidence regarding an association between the nitrofuran and sulfonamide classes of antibiotics and birth defects is mixed As with all patients antibiotics should be prescribed for pregnant women only for appropriate indications and for the shortest effective duration During the secon...

June 2011

PDF Format

Vitamin D: Screening and Supplementation During Pregnancy

Number 495

(Reaffirmed 2015)

ABSTRACT During pregnancy severe maternal vitamin D deficiency has been associated with biochemical evidence of disordered skeletal homeostasis congenital rickets and fractures in the newborn At this time there is insufficient evidence to support a recommendation for screening all pregnant women f...

July 2011

PDF Format

At-Risk Drinking and Alcohol Dependence: Obstetric and Gynecologic Implications

Number 496

(Reaffirmed 2013)

ABSTRACT Compared with men atrisk alcohol use by women has a disproportionate effect on their health and lives including reproductive function and pregnancy outcomes Obstetriciangynecologists have a key role in screening and providing brief intervention patient education and treatment referral for...

August 2011

PDF Format

American Congress of Obstetricians and Gynecologists
409 12th Street SW, Washington, DC  20024-2188 | Mailing Address: PO Box 70620, Washington, DC 20024-9998